Aggrey began his career as a Radiation Protection Officer with the Government of Kenya before moving to Kenyatta National Hospital as a Medical Physicist. He is currently the Chairman of Association of Medical Physicists of Kenya (AMPKen) and has been a part-time Lecturer at the Technical University of Kenya (TUK)

He holds a Bachelor of Science degree in Physics from the University of Nairobi Kenya, and Master of Science in Medical Physics from the University of Surrey, United Kingdom where he was awarded Hounsfield Prize for the best dissertation in Medical Physics program at the University of Surrey, UK

He received his Clinical training in Medical Physics from the Royal Surrey County Hospital and has been a fellow of Stellenbosch University, South Africa. He has attended several short trainings organized by the International Atomic Energy Agency (IAEA) in Kenya, South Africa, Algeria, Tunisia, Nigeria, Tanzania, Austria and USA

He serves on the Cancer Project Implementation team for Kenyatta National Hospital and sits on the Technical Advisory Committee of the National Cancer Institute. He is also a member of the Kenya Research Reactor Project team.

Dr Gakinya is an Assistant Professor & Consultant Pathologist at the Aga Khan University Hospital. He is the Oncopathology Fellowship Director in the Department of Pathology at the Aga Khan University.

Chief Medical Specialist MTRH 2 Clinical & Radiation Oncology
Director: Hemato-Oncology Directorate, Moi Teaching & Referral Hospital, Eldoret Kenya

Positions and Honors

2006 – 2007 Medical officer intern at Kitale District Hospital

2008 – 2010 Medical Officer Moi Teaching and Referral Hospital

2010 – 2015 Residency training in Clinical and Radiation Oncology – University of Stellenbosch, and Fellowship of the College of Radiation Oncologists of South Africa.
2015 – Date Medical Specialist MTRH 4, Consultant in Clinical and Radiation Oncology at Moi Teaching and Referral Hospital (MTRH).

2017 November to Date: Director- Directorate of Hemato-Oncology MTRH 2019June: Senior Medical Specialist MTRH 3

2022 September: Chief Medical Specialist MTRH 2

Peer-reviewed Publication

Results of Radioactive Iodine (131I) Therapy in Well Differentiated Thyroid Carcinoma: A Retrospective Study from the Tygerberg Hospital.
D. Acullu 1* A. E. Fourie 2, K. Baatjes 3 and E. J. Opakas 4 https://www.researchgate.net/publication/283708956_Results_of_Radioactive
_Iodine_131I_Therapy_in_Well_Differentiated_Thyroid_Carcinoma_A_Retrospe ctive_Study_from_the_Tygerberg_Hospital

Radiotherapy in the management of carcinoma of the vulva in HIV positive and negative patients : an institutional experience; Jesse Elungat Opakas https://www.academia.edu/66075078/Radiotherapy_in_the_management_of_ carcinoma_ of_the_vulva_in_HIV_positive_and_negative_patients_an_institutional_experie nce 2015

Nazik Hammad is a Professor at the Division of Medical Oncology, Queen’s University, Kingston Health Science Center, Ontario, Canada. She is the Chair of the Education and Training Committee of the African Organization in Research and Training in Cancer (AORTIC). Prof. Hammad is a visiting professor at the University of Nairobi, Kenya. She is the co-chair of the Network for Advancing Black Learners (Medical Students and Residents) in Ontario. She is the former Director of Global Health, Faculty of Health Sciences at Queen’s University. She is an executive member of the Global Oncology Program at Queen’s University. She treats GI, breast and brain tumours.

Prof. Hammad has a keen interest in medical education, in particular health professions education in low and –middle-income countries (LMIC) and cancer workforce development.  She has a Master degree in Medical Education in the Health Professions (MEHP) from Johns Hopkins University. She teaches regularly at the Clinical Oncology Training Program in Khartoum, Sudan and as a visiting professor at the Medical Oncology Fellowship Training Program, University of Nairobi, Kenya.

Her areas of expertise include training program development and evaluation, accreditation, curriculum development, mentoring and innovations in education. Her work on education has been presented at international conferences and published in peer-reviewed journals. She is a recipient of several grants in education including the Royal College of Physicians and Surgeons of Canada International Development, Aid and Collaboration Grant in 2020 for Faculty Development among African Oncologists.  Her other areas of interest include value in cancer care.

Together with colleagues in African she led the first Choosing Wisely Africa that was recently published in the Journal of Global Oncology. 

Emiola Oluwabunmi Olapade-Olaopa is a professor of Surgery at the University of Ibadan, and an Honorary Consultant Urologist to the University College Hospital, Ibadan (with special focus on Prostate Cancer, Reconstruction and Endourology). His academic and professional careers span surgery, urology, molecular biology, medical education, and health systems research and development. He is the Immediate-Past Provost of the College of Medicine, University of Ibadan, and has been an Adviser on health-professionals training and health systems development to several African countries, the WHO, and the United States and Norwegian Governments. He is currently the President of the African Medical Schools Association; and Chairman, Membership Section of Africa and the Middle-East, of the Societe Internationale d’Urologie. He has a Patent and over 150 publications and 200 national and international research presentations. He is a Fellow of the Nigerian Academies of Science; Medicine, and Medicine Specialties.